AP NEWS
This content is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation.
PRESS RELEASE from provider: Business Wire
This content is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation.

Global Alzheimer’s Disease Clinical Trials Review, H2, 2018 Featuring Pfizer, J&J, Eisai Co, F. Hoffmann-La Roche, Eli Lilly and Co, Novartis, AstraZeneca, Allergan, GlaxoSmithKline & AbbVie - ResearchAndMarkets.com

February 25, 2019

DUBLIN--(BUSINESS WIRE)--Feb 25, 2019--The “Alzheimer’s Disease Global Clinical Trials Review, H2, 2018” clinical trials has been added to ResearchAndMarkets.com’s offering.

“Alzheimer’s Disease Global Clinical Trials Review, H2, 2018” provides an overview of Alzheimer’s Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Alzheimer’s Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe.

The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). These reports are generated using a proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

Scope

Key Topics Covered:

Companies Mentioned

For more information about this clinical trials report visit https://www.researchandmarkets.com/research/m8h8v6/global?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20190225005516/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Clinical Trials,Alzheimer’s Disease Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH CLINICAL TRIALS MENTAL HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 02/25/2019 07:41 AM/DISC: 02/25/2019 07:41 AM

http://www.businesswire.com/news/home/20190225005516/en